Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Renton (2000)
Hepatic drug metabolism and immunostimulation.Toxicology, 142 3
T. Nolin, R. Frye, G. Matzke (2003)
Hepatic drug metabolism and transport in patients with kidney disease.American journal of kidney diseases : the official journal of the National Kidney Foundation, 42 5
S. Ke, A. Rabson, J. Germino, M. Gallo, Yanan Tian (2001)
Mechanism of Suppression of Cytochrome P-450 1A1 Expression by Tumor Necrosis Factor-α and Lipopolysaccharide*The Journal of Biological Chemistry, 276
O. Barbier, H. Girard, Y. Inoue, H. Duez, L. Villeneuve, A. Kamiya, J. Fruchart, C. Guillemette, F. Gonzalez, B. Staels (2005)
Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4αMolecular Pharmacology, 67
A. El-Kadi, A. Bleau, I. Dumont, H. Maurice, P. Souich (2000)
Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction.Drug metabolism and disposition: the biological fate of chemicals, 28 9
R. McGehee, M. Ronis, T. Badger (1997)
Regulation of the hepatic CYP 2E1 gene during chronic alcohol exposure: lack of an ethanol response element in the proximal 5'-flanking sequence.DNA and cell biology, 16 6
R. Memon, A. Moser, J. Shigenaga, C. Grunfeld, K. Feingold (2001)
In Vivo and in Vitro Regulation of Sterol 27-Hydroxylase in the Liver during the Acute Phase ResponseThe Journal of Biological Chemistry, 276
T. Barclay, J. Peters, M. Sewer, L. Ferrari, F. Gonzalez, E. Morgan (1999)
Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.The Journal of pharmacology and experimental therapeutics, 290 3
G. Bánhegyi, I. Mucha, T. Garzó, F. Antoni, J. Mandl (1995)
Endotoxin inhibits glucuronidation in the liver. An effect mediated by intercellular communication.Biochemical pharmacology, 49 1
Mihaela Levitchi, C. Fradette, A. Bleau, Dorothée Michaud, Oksana Kourylko, M. Arcand, P. Souich (2004)
Signal transduction pathways implicated in the decrease in CYP1A1, 1A2 and 3A6 activity produced by serum from rabbits and humans with an inflammatory reaction.Biochemical pharmacology, 68 3
H. Hara, T. Adachi (2002)
Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide.Molecular pharmacology, 61 1
Ting Su, Xinxin Ding (2004)
Regulation of the cytochrome P450 2A genes.Toxicology and applied pharmacology, 199 3
A. Beigneux, A. Moser, J. Shigenaga, C. Grunfeld, K. Feingold (2000)
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver*The Journal of Biological Chemistry, 275
Hsia-lien Lin, U. Kent, Haoming Zhang, L. Waskell, P. Hollenberg (2003)
Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite.Chemical research in toxicology, 16 2
E. Siewert, C. Dietrich, F. Lammert, P. Heinrich, S. Matern, C. Gartung, A. Geier (2004)
Interleukin-6 regulates hepatic transporters during acute-phase response.Biochemical and biophysical research communications, 322 1
E. Siewert, R. Bort, R. Kluge, P. Heinrich, J. Castell, R. Jover (2000)
Hepatic cytochrome P450 down‐regulation during aseptic inflammation in the mouse is interleukin 6 dependentHepatology, 32
M. Pitarque, C. Rodríguez‐Antona, M. Oscarson, M. Ingelman-Sundberg (2005)
Transcriptional Regulation of the Human CYP2A6 GeneJournal of Pharmacology and Experimental Therapeutics, 313
Ning Li, S. Choudhuri, N. Cherrington, C. Klaassen (2004)
Down-regulation of mouse organic anion-transporting polypeptide 4 (Oatp4; Oatp1b2; Slc21a10) mRNA by lipopolysaccharide through the toll-like receptor 4 (TLR4).Drug metabolism and disposition: the biological fate of chemicals, 32 11
C. Vossen, M. Erard (2002)
Down-regulation of nuclear receptor DNA-binding activity by nitric oxide--HNF4 as a model system.Medical science monitor : international medical journal of experimental and clinical research, 8 10
J. Ros, J. Schuetz, M. Geuken, K. Streetz, H. Moshage, F. Kuipers, M. Manns, P. Jansen, C. Trautwein, Michaela Müller (2001)
Induction of Mdr1b expression by tumor necrosis factor‐α in rat liver cells is independent of p53 but requires NF‐κB signalingHepatology, 33
W. Kozak, K. Mayfield, A. Kozák, M. Kluger (2000)
Proadifen (SKF-525A), an inhibitor of cytochrome P-450, augments LPS-induced fever and exacerbates prostaglandin-E2 levels in the ratJournal of Thermal Biology, 25
Y. Shimamoto, H. Kitamura, M. Iwai, M. Saito, A. Kazusaka, S. Fujita (1999)
Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: independence from sympathetic nervous and adrenocortical systemsArchives of Toxicology, 73
W. Kozak, Inez Archuleta, Kimberly Mayfield, Anna Kozak, Karin Rudolph, M. Kluger (1998)
Inhibitors of alternative pathways of arachidonate metabolism differentially affect fever in mice.The American journal of physiology, 275 4
R. Green, D. Beier, J. Gollan (1996)
Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents.Gastroenterology, 111 1
Heinrich Iber, Marion Sewer, Thomas Barclay, Stephanie Mitchell, Tong Li, Edward Morgan (1999)
Modulation of drug metabolism in infectious and inflammatory diseases.Drug metabolism reviews, 31 1
M. Ogino, K. Nagata, M. Miyata, Y. Yamazoe (1999)
Hepatocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and its modes of modulation by apolipoprotein AI regulatory protein I and v-ErbA-related protein 3.Archives of biochemistry and biophysics, 362 1
M. Sewer, D. Koop, E. Morgan (1996)
Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.Drug metabolism and disposition: the biological fate of chemicals, 24 4
G. Denk, C. Soroka, Y. Takeyama, Wen-sheng Chen, J. Schuetz, J. Boyer (2004)
Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.Journal of hepatology, 40 4
K. Ogawa, H. Suzuki, T. Hirohashi, T. Ishikawa, P. Meier, K. Hirose, T. Akizawa, M. Yoshioka, Y. Sugiyama (2000)
Characterization of inducible nature of MRP3 in rat liver.American journal of physiology. Gastrointestinal and liver physiology, 278 3
M. Coughtrie (2002)
Sulfation through the looking glass—recent advances in sulfotransferase research for the curiousThe Pharmacogenomics Journal, 2
A. Schinkel, J. Smit, O. Tellingen, J. Beijnen, E. Wagenaar, L. Deemter, C. Mol, M. Valk, E. Robanus-Maandag, H. Riele, A. Berns, P. Borst (1994)
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 77
R. Jover, R. Bort, M. Gómez‐Lechón, J. Castell (2002)
Down‐regulation of human CYP3A4 by the inflammatory signal interleukin 6: molecular mechanism and transcription factors involvedThe FASEB Journal, 16
S. Ryu, Ju-Hee Kang, H. Yi, C. Nahm, Chang-Shin Park (2004)
Hepatic flavin-containing monooxygenase activity attenuated by cGMP-independent nitric oxide-mediated mRNA destabilization.Biochemical and biophysical research communications, 324 1
T. Richardson, E. Morgan (2005)
Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout MiceJournal of Pharmacology and Experimental Therapeutics, 314
S. Callahan, Xin Ming, Shirley Lu, L. Brunner, M. Croyle (2005)
Considerations for Use of Recombinant Adenoviral Vectors: Dose Effect on Hepatic Cytochromes P450Journal of Pharmacology and Experimental Therapeutics, 312
A. Bleau, P. Maurel, V. Pichette, F. Leblond, P. Souich (2003)
Interleukin-1β, interleukin-6, tumour necrosis factor-α and interferon-γ released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytesEuropean Journal of Pharmacology, 473
M. Elferink, P. Olinga, A. Draaisma, M. Merema, K. Faber, M. Slooff, D. Meijer, G. Groothuis (2004)
LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.American journal of physiology. Gastrointestinal and liver physiology, 287 5
R. White, M. Coon (1980)
Oxygen activation by cytochrome P-450.Annual review of biochemistry, 49
E. Johnson, C. Palmer, K. Griffin, M. Hsu (1996)
Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulationThe FASEB Journal, 10
P. Mackenzie, P. Gregory, D. Gardner-Stephen, R. Lewinsky, B. Jorgensen, T. Nishiyama, W. Xie, A. Radomińska-Pandya (2003)
Regulation of UDP glucuronosyltransferase genes.Current drug metabolism, 4 3
A. Roe, S. Poloyac, G. Howard, S. Shedlofsky, R. Blouin (2001)
The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the ratJournal of Pharmacy and Pharmacology, 53
Y. Chen, I. Florentin, A. Batt, L. Ferrari, J. Giroud, L. Chauvelot‐Moachon (1992)
Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat.Biochemical pharmacology, 44 1
N. Cherrington, A. Slitt, Ning Li, C. Klaassen (2004)
Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.Drug metabolism and disposition: the biological fate of chemicals, 32 7
B. Oesch-Bartlomowicz, F. Oesch (2002)
Fast Regulation of Cytochrome P450 Activities by Phosphorylation and Consequences for Drug Metabolism and Toxicity, 383
K. Renton (2001)
Alteration of drug biotransformation and elimination during infection and inflammation.Pharmacology & therapeutics, 92 2-3
B. Oesch-Bartlomowicz, F. Oesch (2003)
Cytochrome-P450 phosphorylation as a functional switch.Archives of biochemistry and biophysics, 409 1
P. Majano, Carmelo García-Monzón, Manuel López-Cabrera, Enrique Lara-Pezzi, Elena Fernández-Ruiz, Consuelo García‐Iglesias, M. Borque, Ricardo Moreno-Otero (1998)
Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.The Journal of clinical investigation, 101 7
R. Whalen, S. Voss, T. Boyer (2004)
Decreased expression levels of rat liver glutathione S-transferase A2 and albumin during the acute phase response are mediated by HNF1 (hepatic nuclear factor 1) and IL6DEX-NP.The Biochemical journal, 377 Pt 3
F. Guengerich (2003)
Cytochromes P450, drugs, and diseases.Molecular interventions, 3 4
G. Fantuzzi, M. Demitri, P. Ghezzi (1994)
Differential effect of glucocorticoids on tumour necrosis factor production in mice: up‐regulation by early pretreatment with dexamethasoneClinical & Experimental Immunology, 96
O. Barbier, Daniel Durán-Sandoval, I. Pineda-Torra, V. Kosykh, J. Fruchart, B. Staels (2003)
Peroxisome Proliferator-activated Receptor α Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme*Journal of Biological Chemistry, 278
R. Vuppugalla, R. Mehvar (2004)
Hepatic Disposition and Effects of Nitric Oxide Donors: Rapid and Concentration-Dependent Reduction in the Cytochrome P450-Mediated Drug Metabolism in Isolated Perfused Rat LiversJournal of Pharmacology and Experimental Therapeutics, 310
T. Buetler (1998)
Identification of glutathione S‐transferase isozymes and γ‐glutamylcysteine synthetase as negative acute‐phase proteins in rat liverHepatology, 28
Sang-Won Park, Sun-Mee Lee (2004)
The beneficial effect of trolox on sepsis-induced hepatic drug metabolizing dysfunctionArchives of Pharmacal Research, 27
W. Gilmore, G. Hartmann, M. Piquette-Miller, J. Marriott, G. Kirby (2003)
Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.Toxicology, 184 2-3
Yan Chen, Valérie Vraux, Anne Leneveu, F. Dreyfus, Anne Stheneur, I. Florentin, M. Sousa, J. Giroud, Bernard Flouvat, L. Chauvelot‐Moachon (1994)
Acute‐phase response, interleukin‐6, and alteration of cyclosporine pharmacokineticsClinical Pharmacology & Therapeutics, 55
Carrie Cantwell, E. Sterneck, P. Johnson (1998)
Interleukin-6-Specific Activation of the C/EBPδ Gene in Hepatocytes Is Mediated by Stat3 and Sp1Molecular and Cellular Biology, 18
M. Piquette-Miller, A. Pak, H. Kim, R. Anari, Afshin Shahzamani (1998)
Decreased Expression and Activity of P-GIycoprotein in Rat Liver During Acute InflammationPharmaceutical Research, 15
V. Wacher, J. Silverman, Y. Zhang, L. Benet (1998)
Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics.Journal of pharmaceutical sciences, 87 11
J. Carcillo, L. Doughty, Danny Kofos, R. Frye, S. Kaplan, H. Sasser, G. Burckart (2003)
Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failureIntensive Care Medicine, 29
Y. Masubuchi, T. Horie (2004)
Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.Drug metabolism and disposition: the biological fate of chemicals, 32 4
E. Szczesna-Skorupa, Cidi Chen, Hong Liu, B. Kemper (2004)
Gene Expression Changes Associated with the Endoplasmic Reticulum Stress Response Induced by Microsomal Cytochrome P450 Overproduction*Journal of Biological Chemistry, 279
S. Lyoumi, H. Puy, F. Tamion, C. Bogard, A. Leplingard, M. Scotté, R. Vranckx, F. Gauthier, M. Hiron, M. Daveau, Y. Nordmann, J. Deybach, J. Lebreton (1999)
Heme and acute inflammationFEBS Journal, 261
M. Congiu, M. Mashford, J. Slavin, P. Desmond (2002)
UDP glucuronosyltransferase mRNA levels in human liver disease.Drug metabolism and disposition: the biological fate of chemicals, 30 2
C. Haas, David Kaufman, Carolyn Jones, A. Burstein, W. Reiss (2003)
Cytochrome P450 3A4 activity after surgical stressCritical Care Medicine, 31
Y. Minamiyama, Shigekazu Takemura, S. Imaoka, Y. Funae, Yuko Tanimoto, Masayasu Inoue (1997)
Irreversible inhibition of cytochrome P450 by nitric oxide.The Journal of pharmacology and experimental therapeutics, 283 3
J. Nakamura, T. Nishida, Ken’ichiro Hayashi, N. Kawada, S. Ueshima, Y. Sugiyama, T. Ito, K. Sobue, H. Matsuda (1999)
Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression.Biochemical and biophysical research communications, 255 1
Y. Minamiyama, S. Takemura, S. Toyokuni, S. Imaoka, Y. Funae, K. Hirohashi, T. Yoshikawa, S. Okada (2004)
CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats.Free radical biology & medicine, 37 5
S. Teng, M. Piquette-Miller (2005)
The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in MiceJournal of Pharmacology and Experimental Therapeutics, 312
S. Voss, Y. Park, S. Kwon, R. Whalen, T. Boyer (1996)
Role of interleukin 6 and corticosteroids in the regulation of expression of glutathione S-transferases in primary cultures of rat hepatocytes.The Biochemical journal, 317 ( Pt 2)
P. Gervois, N. Vu-dac, R. Kleemann, M. Kockx, G. Dubois, B. Laine, V. Kosykh, J. Fruchart, T. Kooistra, B. Staels (2001)
Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β*The Journal of Biological Chemistry, 276
R. Balk (2000)
Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock.Critical care clinics, 16 2
G. Chinetti, J. Fruchart, B. Staels (2003)
Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applicationsInternational Journal of Obesity, 27
J. Cashman (2003)
The role of flavin-containing monooxygenases in drug metabolism and development.Current opinion in drug discovery & development, 6 4
S. Strasser, M. Mashford, P. Desmond (1998)
Regulation of uridine diphosphate glucuronosyltransferase during the acute‐phase responseJournal of Gastroenterology and Hepatology, 13
E. Assenat, S. Gerbal-Chaloin, D. Larrey, J. Saric, J. Fabre, P. Maurel, M. Vilarem, J. Pascussi (2004)
Interleukin 1β inhibits CAR‐induced expression of hepatic genes involved in drug and bilirubin clearanceHepatology, 40
R. Green, James Whiting, A. Rosenbluth, D. Beier, J. Gollan (1994)
Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity.The American journal of physiology, 267 6 Pt 1
E. Giannini, A. Fasoli, F. Botta, P. Romagnoli, F. Malfatti, B. Chiarbonello, M. Mamone, V. Savarino, R. Testa (2003)
Helicobacter pylori Infection Is Associated with Greater Impairment of Cytochrome P-450 Liver Metabolic Activity in Anti-HCV Positive Cirrhotic PatientsDigestive Diseases and Sciences, 48
G. Fantuzzi, L. Cantoni, M. Sironi, P. Ghezzi (1993)
Inhibitors of cytochrome P450 suppress tumor necrosis factor production.Cellular immunology, 150 2
C. Fang, Seokjoo Yoon, N. Tindberg, H. Järveläinen, K. Lindros, M. Ingelman-Sundberg (2004)
Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure.Biochemical pharmacology, 67 7
A. Beigneux, A. Moser, J. Shigenaga, C. Grunfeld, K. Feingold (2002)
Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response.Biochemical and biophysical research communications, 293 1
R. Vuppugalla, R. Mehvar (2004)
SHORT-TERM INHIBITORY EFFECTS OF NITRIC OXIDE ON CYTOCHROME P450-MEDIATED DRUG METABOLISM: TIME DEPENDENCY AND REVERSIBILITY PROFILES IN ISOLATED PERFUSED RAT LIVERSDrug Metabolism and Disposition, 32
Gigi Lee, M. Piquette-Miller (2003)
Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.Journal of pharmaceutical sciences, 92 11
S. Mitchell, R. Ayesh, T. Barrett, R. Smith (1999)
Trimethylamine and foetor hepaticus.Scandinavian journal of gastroenterology, 34 5
C. Martinez-Jimenez, M. Gómez‐Lechón, J. Castell, R. Jover (2005)
Transcriptional Regulation of the Human Hepatic CYP3A4: Identification of a New Distal Enhancer Region Responsive to CCAAT/Enhancer-Binding Protein β Isoforms (Liver Activating Protein and Liver Inhibitory Protein)Molecular Pharmacology, 67
Thera Vos, G. Hooiveld, H. Koning, S. Childs, D. Meijer, H. Moshage, P. Jansen, Michaela Müller (1998)
Up‐regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down‐regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liverHepatology, 28
A. Bleau, Mihaela Levitchi, H. Maurice, P. Souich (2000)
Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine‐induced inflammation: the role of cytokinesBritish Journal of Pharmacology, 130
A. Schinkel, U. Mayer, E. Wagenaar, C. Mol, L. Deemter, J. Smit, M. Valk, A. Voordouw, H. Spits, O. Tellingen, J. Zijlmans, W. Fibbe, P. Borst (1997)
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.Proceedings of the National Academy of Sciences of the United States of America, 94 8
(2003)
Nuclear Receptor BioMed Central
A. Radominska, Susan Treat, Joanna Little (1993)
Bile Acid Metabolism and the Pathophysiology of CholestasisSeminars in Liver Disease, 13
De-xiang Xu, Wei Wei, Meifang Sun, Ling‐Zhen Wei, Jianping Wang (2005)
Melatonin attenuates lipopolysaccharide‐induced down‐regulation of pregnane X receptor and its target gene CYP3A in mouse liverJournal of Pineal Research, 38
De-xiang Xu, Wei Wei, Meifang Sun, Cheng-Yi Wu, Jianping Wang, Ling‐Zhen Wei, Cheng-Fan Zhou (2004)
Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver.Free radical biology & medicine, 37 1
M. Haack, M. Bak, R. Beurskens, Michael Maes, P. Delespaul (2003)
Toxic rise of clozapine plasma concentrations in relation to inflammationEuropean Neuropsychopharmacology, 13
E. Morgan (2001)
Regulation of cytochrome p450 by inflammatory mediators: why and how?Drug metabolism and disposition: the biological fate of chemicals, 29 3
G. Warren, S. Poloyac, Devin Gary, Mark Mattson, Robert Blouin (1999)
Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration.The Journal of pharmacology and experimental therapeutics, 288 3
R. Kubitz, M. Wettstein, U. Warskulat, D. Häussinger (1999)
Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone.Gastroenterology, 116 2
S. Ryu, H. Yi, Y. Cha, Ju-Hee Kang, Juanxia Kang, Y. Jeon, H. Park, Tae-Moo Yu, Jung-Nam Lee, Chang-Shin Park (2004)
Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.Life sciences, 75 21
Xue-Qing Li, T. Andersson, Marie Ahlström, L. Weidolf (2004)
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.Drug metabolism and disposition: the biological fate of chemicals, 32 8
P. Cheng, Molin Wang, E. Morgan (2003)
Rapid Transcriptional Suppression of Rat Cytochrome P450 Genes by Endotoxin Treatment and Its Inhibition by CurcuminJournal of Pharmacology and Experimental Therapeutics, 307
K. Sachdeva, B. Yan, C. Chichester (2003)
Lipopolysaccharide and Cecal Ligation/Puncture Differentially Affect the Subcellular Distribution of the Pregnane X Receptor but Consistently Cause Suppression of Its Target Genes CYP3AShock, 19
O. Barbier, L. Villeneuve, V. Bocher, C. Fontaine, I. Torra, C. Duhem, V. Kosykh, J. Fruchart, C. Guillemette, B. Staels (2003)
The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor α and γ Target Gene*The Journal of Biological Chemistry, 278
H. Iber, Qi Chen, Po-Yung Cheng, E. Morgan (2000)
Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site.Archives of biochemistry and biophysics, 377 1
T. Ashino, T. Oguro, S. Shioda, R. Horai, M. Asano, K. Sekikawa, Y. Iwakura, S. Numazawa, Takemi Yoshida (2004)
Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver.Drug metabolism and disposition: the biological fate of chemicals, 32 7
Kyle Christian, M. Lang, P. Maurel, F. Raffalli-Mathieu (2004)
Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA: implications for post-transcriptional regulation of the CYP2A6 gene.Molecular pharmacology, 65 6
S. Choi, S. Kim (1998)
Lipopolysaccharide inhibition of rat hepatic microsomal epoxide hydrolase and glutathione S-transferase gene expression irrespective of nuclear factor-kappaB activation.Biochemical pharmacology, 56 11
K. Goralski, Dalya Abdulla, C. Sinal, A. Arsenault, K. Renton (2005)
Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation.American journal of physiology. Gastrointestinal and liver physiology, 289 3
Valerie Turan, Vladimir Mishin, Paul Thomas (2001)
Clotrimazole is a selective and potent inhibitor of rat cytochrome P450 3A subfamily-related testosterone metabolism.Drug metabolism and disposition: the biological fate of chemicals, 29 6
F. Leblond, C. Guévin, C. Demers, I. Pellerin, M. Gascon-Barré, V. Pichette (2001)
Downregulation of hepatic cytochrome P450 in chronic renal failure.Journal of the American Society of Nephrology : JASN, 12 2
H. Baumann, K. Morella, S. Campos, Z. Cao, G. Jahreis (1992)
Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes.The Journal of biological chemistry, 267 27
L. Caradonna, L. Amati, Thea Magrone, N. Pellegrino, E. Jirillo, D. Caccavo (2000)
Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significanceJournal of Endotoxin Research, 6
Soo-Hee Park, D. Waxman (2001)
Inhibitory Cross-talk between STAT5b and Liver Nuclear Factor HNF3βThe Journal of Biological Chemistry, 276
M. Monshouwer, R.F Witkamp, S. Nijmeijer, Jan Amsterdam, Adelbert Miert (1996)
Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes.Toxicology and applied pharmacology, 137 2
M. Nakajima, K. Iwata, T. Yamamoto, Y. Funae, T. Yoshida, Y. Kuroiwa (1998)
Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis.Drug metabolism and disposition: the biological fate of chemicals, 26 1
J. Crawford, Shaolong Yang, Mian Zhou, H. Simms, Ping Wang (2004)
Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsisCritical Care Medicine, 32
M. Shimada, E. Watanabe, Y. Iida, K. Nagata, Y. Yamazoe (1999)
Alteration of hepatic sulfation by endotoxin.Japanese journal of pharmacology, 80 4
H. Renz, A. Henke, P. Hofmann, L. Wolff, A. Schmidt, J. Rüschoff, D. Gemsa (1992)
Sensitization of rat alveolar macrophages to enhanced TNF-alpha release by in vivo treatment with dexamethasone.Cellular immunology, 144 2
M. Trauner, M. Arrese, Hyejin Lee, J. Boyer, S. Karpen (1998)
Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.The Journal of clinical investigation, 101 10
Lauretta Chan, S. Lowes, B. Hirst (2004)
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 21 1
M. Trauner, Peter Meier, J. Boyer (2012)
Molecular pathogenesis of cholestasis.The New England journal of medicine, 339 17
W. Kozak, M. Kluger, Anna Kozak, Maciej Wachulec, Karol Dokladny (2000)
Role of cytochrome P-450 in endogenous antipyresis.American journal of physiology. Regulatory, integrative and comparative physiology, 279 2
M. Trauner, M. Arrese, C. Soroka, M. Ananthanarayanan, T. Koeppel, S. Schlosser, F. Suchy, D. Keppler, J. Boyer (1997)
The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis.Gastroenterology, 113 1
L. Ferrari, N. Peng, J. Halpert, E. Morgan (2001)
Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes.Molecular pharmacology, 60 1
K. Mahéo, J. Antras‐Ferry, F. Morel, S. Langouët, A. Guillouzo (1997)
Modulation of Glutathione S-Transferase Subunits A2, M1, and P1 Expression by Interleukin-1β in Rat Hepatocytes in Primary Culture*The Journal of Biological Chemistry, 272
J. Carcillo, K. Korzekwa, G. Jones, R. Parise, Delbert Gillespie, M. Whalen, P. Kochanek, R. Branch, C. Kost (1998)
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.Research communications in molecular pathology and pharmacology, 102 1
Min Kim, J. Shigenaga, A. Moser, C. Grunfeld, K. Feingold (2004)
Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.American journal of physiology. Endocrinology and metabolism, 287 4
K. Renton (2004)
Cytochrome P450 regulation and drug biotransformation during inflammation and infection.Current drug metabolism, 5 3
Min Kim, J. Shigenaga, A. Moser, K. Feingold, C. Grunfeld (2003)
Repression of Farnesoid X Receptor during the Acute Phase Response*The Journal of Biological Chemistry, 278
G. Hartmann, A. Cheung, M. Piquette-Miller (2002)
Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in EndotoxemiaJournal of Pharmacology and Experimental Therapeutics, 303
L. Rivory, Kellie Slaviero, Stephen Clarke (2002)
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase responseBritish Journal of Cancer, 87
M. Sukhai, A. Yong, J. Kalitsky, M. Piquette-Miller (2000)
Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes.Molecular cell biology research communications : MCBRC, 4 4
J. Pappas, M. Franklin (1993)
Hepatic clotrimazole concentrations and hepatic drug metabolizing enzyme activities in adult male Sprague-Dawley rats.Toxicology, 80 1
M. Sewer, Dennis Koop, Edward Morgan (1997)
Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression.The Journal of pharmacology and experimental therapeutics, 280 3
S. Voss, R. Whalen, T. Boyer (2002)
Mechanism of negative regulation of rat glutathione S-transferase A2 by the cytokine interleukin 6.The Biochemical journal, 365 Pt 1
C. Song, M. Jung, Sang Kim, Tina Hassan, A. Roy, B. Chatterjee (1998)
Tissue-specific and Androgen-repressible Regulation of the Rat Dehydroepiandrosterone Sulfotransferase Gene Promoter*The Journal of Biological Chemistry, 273
Kellie Slaviero, S. Clarke, L. Rivory (2003)
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy.The Lancet. Oncology, 4 4
Ning Li, C. Klaassen (2004)
Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.Toxicological sciences : an official journal of the Society of Toxicology, 83 1
T. Nakashima, Y. Harada, S. Miyata, T. Kiyohara (1996)
Inhibitors of cytochrome P-450 augment fever induced by interleukin-1 beta.The American journal of physiology, 271 5 Pt 2
James Whiting, R. Green, A. Rosenbluth, J. Gollan (1995)
Tumor necrosis factor–alpha decreases hepatocyte bile salt uptake and mediates endotoxin‐induced cholestasisHepatology, 22
Éric Lévesque, M. Beaulieu, C. Guillemette, D. Hum, Alain Bélanger (1998)
Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.Endocrinology, 139 5
C. Park, H. Baek, W. Chung, K. Lee, S. Ryu, Y. Cha (1999)
Suppression of flavin-containing monooxygenase by overproduced nitric oxide in rat liver.Molecular pharmacology, 56 3
A. Geier, C. Dietrich, S. Voigt, S. Kim, T. Gerloff, G. Kullak-Ublick, J. Lorenzen, S. Matern, C. Gartung (2003)
Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasisHepatology, 38
E. Roberts, Hsia-lien Lin, J. Crowley, J. Vuletich, Yoichi Osawa, P. Hollenberg (1998)
Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1.Chemical research in toxicology, 11 9
K. Mahéo, F. Morel, J. Antras‐Ferry, S. Langouët, F. Desmots, L. Corcos, A. Guillouzo (1998)
Endotoxin suppresses the oltipraz‐mediated induction of major hepatic glutathione transferases and cytochromes P450 in the ratHepatology, 28
G. Fantuzzi, G. Galli, M. Zinetti, M. Fratelli, P. Ghezzi (1995)
The upregulating effect of dexamethasone on tumor necrosis factor production is mediated by a nitric oxide-producing cytochrome P450.Cellular immunology, 160 2
Duo Li, T. Zimmerman, S. Thevananther, Ho-Yyoung Lee, J. Kurie, S. Karpen (2002)
Interleukin-1β-mediated Suppression of RXR:RAR Transactivation of the Ntcp Promoter Is JNK-dependent*The Journal of Biological Chemistry, 277
G. Hartmann, Hani Kim, M. Piquette-Miller (2001)
Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice.International immunopharmacology, 1 2
H. Kashima, J. Tanemura, T. Hasegawa, E. Oda, T. Muramatsu, T. Kusunoki (2001)
Unidimensional Scale for DementiaDementia and Geriatric Cognitive Disorders, 12
O. Barbier, I. Torra, Audrey Sirvent, T. Claudel, C. Blanquart, Daniel Durán-Sandoval, F. Kuipers, V. Kosykh, J. Fruchart, B. Staels (2003)
FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.Gastroenterology, 124 7
G. Hartmann, V. Vassileva, M. Piquette-Miller (2005)
IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICEDrug Metabolism and Disposition, 33
M. Miyoshi, M. Nadai, A. Nitta, J. Ueyama, Akemi Shimizu, K. Takagi, T. Nabeshima, K. Takagi, Kuniaki Saito, T. Hasegawa (2005)
Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin.European journal of pharmacology, 507 1-3
E. Morgan (1997)
Regulation of cytochromes P450 during inflammation and infection.Drug metabolism reviews, 29 4
G. Zollner, P. Fickert, D. Silbert, A. Fuchsbichler, C. Stumptner, K. Zatloukal, H. Denk, M. Trauner (2002)
Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice.American journal of physiology. Gastrointestinal and liver physiology, 282 1
M. Donner, U. Warskulat, N. Saha, D. Häussinger (2004)
Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS, 385
P. Ruminy, C. Gangneux, S. Claeyssens, Michel Scotté, M. Daveau, Jean-Philippe Salier (2001)
Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genesInflammation Research, 50
M. An, C. Hsieh, P. Reisner, J. Rabek, S. Scott, D. Kuninger, J. Papaconstantinou (1996)
Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase responseMolecular and Cellular Biology, 16
T. Levade, N. Augé, R. Veldman, O. Cuvillier, A. Nègre-Salvayre, R. Salvayre (2001)
Sphingolipid mediators in cardiovascular cell biology and pathology.Circulation research, 89 11
Stephanie Mitchell, M. Sewer, Sean Kardar, Edward Morgan (2001)
Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia.Drug metabolism and disposition: the biological fate of chemicals, 29 1
▪ Abstract Inflammation and infection have long been known to downregulate the activity and expression of cytochrome P450 (CYP) enzymes involved in hepatic drug clearance. This can result in elevated plasma drug levels and increased adverse effects. Recent information on regulation of human CYP enzymes is presented, as are new developments in our understanding of the mechanisms of regulation. Experiments to study the effects of modulating CYP activities on the inflammatory response have yielded possible insights into the physiological consequences, if not the purpose, of the downregulation. Regulation of hepatic flavin monooxygenases, UDP-glucuronosyltransferases, sulfotransferases, glutathione S-transferases, as well as of hepatic transporters during the inflammatory response, exhibits similarities and differences with regulation of CYPs.
Annual Review of Pharmacology and Toxicology – Annual Reviews
Published: Feb 10, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.